GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Mirion Technologies Inc (NYSE:MIR) » Definitions » Change In Receivables

MIR (Mirion Technologies) Change In Receivables : $-22.9 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Mirion Technologies Change In Receivables?

Mirion Technologies's change in receivables for the quarter that ended in Mar. 2025 was $29.0 Mil. It means Mirion Technologies's Accounts Receivable declined by $29.0 Mil from Dec. 2024 to Mar. 2025 .

Mirion Technologies's change in receivables for the fiscal year that ended in Dec. 2024 was $-35.9 Mil. It means Mirion Technologies's Accounts Receivable increased by $35.9 Mil from Dec. 2023 to Dec. 2024 .

Mirion Technologies's Accounts Receivable for the quarter that ended in Mar. 2025 was $147.8 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Mirion Technologies's Days Sales Outstanding for the three months ended in Mar. 2025 was 66.77.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Mirion Technologies's liquidation value for the three months ended in Mar. 2025 was $-694.6 Mil.


Mirion Technologies Change In Receivables Historical Data

The historical data trend for Mirion Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mirion Technologies Change In Receivables Chart

Mirion Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial - - -19.30 -3.10 -35.90

Mirion Technologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.00 -9.80 -9.50 -32.60 29.00

Mirion Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-22.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mirion Technologies  (NYSE:MIR) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Mirion Technologies's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=147.8/202*91
=66.77

2. In Ben Graham's calculation of liquidation value, Mirion Technologies's accounts receivable are only considered to be worth 75% of book value:

Mirion Technologies's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=191.7-1068.9+0.75 * 147.8+0.5 * 143.5
=-694.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mirion Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Mirion Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Mirion Technologies Business Description

Traded in Other Exchanges
Address
1218 Menlo Drive, Atlanta, GA, USA, 30318
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Executives
Loic Eloy officer: Industrial Group President 1218 MENLO DRIVE, ATLANTA GA 30318
Thomas D Logan director, officer: Chief Executive Officer C/O MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318
Christopher A. Moore officer: Chief Accounting Officer (PAO) C/O MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318
Brian Schopfer officer: Chief Financial Officer MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318
Gsam Holdings Llc director, 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Michael J Rossi officer: Medical Group President 230 PARK AVENUE, SUITE 3350, NEW YORK NY 10169
Sheila Rege director 1218 MENLO DRIVE, ATLANTA GA 30318
Jody Markopoulos director 3641 WOODBOURNE LANE, CROZET VA 22932
Ccp Ix Lp No. 1 10 percent owner 76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Ccp Ix Lp No. 2 10 percent owner 76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Ccp Ix Co-investment Lp 10 percent owner 76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Ccp Ix Co-investment No. 2 Lp 10 percent owner 76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Charterhouse General Partners (ix) Ltd 10 percent owner 76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Kipling Matas officer: Chief Accounting Officer MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318
Christopher L Warren director MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318